Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiography

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 12, 2006, Pages 5460-5468

  Shah, Syed Mahmood ^a   Tatlipinar, Sinan ^a   Quinlan, Edward ^a   Sung, Jennifer U ^a   Tabandeh, Homayoun ^a   Quan, Dong Nguyen ^a   Fahmy, Ahmed S ^b   Zimmer Galler, Ingrid ^a   Symons, R C Andrew ^a   Cedarbaum, Jesse M ^c   Campochiaro, Peter A ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; PHOTOSENSITIZING AGENT; VEGF TRAP R1R2 PROTEIN, CALLITHRIX JACCHUS;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; FLUORESCENCE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MOLECULAR DYNAMICS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SUBRETINAL NEOVASCULARIZATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHASE 1 CLINICAL TRIAL; PHOTOCHEMOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY;

CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RECEPTORS, GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 34248227652     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0012     Document Type: Article

References (8)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
2. Holash J, Davis S, Papadoupoulos N, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA. 2002;99:11393-11398.
3. Nguyen QD, Shah SM, Hafiz G, et al. A phase 1 trial of intravenously administered VEGF trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration. Ophthalmology. 2006;113:1522.e1-1522.e14.
4. Stevens TS, Bressler NM, Maguire MG, et al. Occult choroidal neovascularization in age-related macular degeneration: a natural history study. Arch Ophthalmol. 1997;115:345-350.
5. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report. Arch Ophthalmol. 1999,117:1329-1345.
6. Berger JW. Quantitative image sequence analysis of fundus fluorescein angiography. Ophthalmic Surg Lasers. 1999;30:72-73.
7. Sickenberg M, Ballini JP, van den Bergh H. A computer-based method .to quantify the classic pattern of choroidal neovascularization in order to monitor photodynamic therapy. Graefes Arch Clin Exp Ophthalmol. 1999;237:353-360.
8. Berger JW, Yoken J. Computer-assisted quantitation of choroidal neovascularization for clinical trials. Invest Ophthalmol Vis Sci. 2000;41:2286-2295.